- Home
- GSK vs EPD Comparison
GSK vs EPD Comparison
Compare GSK & EPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- EPD
- Stock Information
- Founded
- GSK 1715
- EPD 1968
- Country
- GSK United Kingdom
- EPD United States
- Employees
- GSK N/A
- EPD N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- EPD Natural Gas Distribution
- Sector
- GSK Health Care
- EPD Utilities
- Exchange
- GSK Nasdaq
- EPD Nasdaq
- Market Cap
- GSK 86.1B
- EPD 69.6B
- IPO Year
- GSK N/A
- EPD 1998
- Fundamental
- Price
- GSK $38.72
- EPD $31.09
- Analyst Decision
- GSK Hold
- EPD Buy
- Analyst Count
- GSK 3
- EPD 11
- Target Price
- GSK N/A
- EPD $36.50
- AVG Volume (30 Days)
- GSK 4.8M
- EPD 3.8M
- Earning Date
- GSK 07-30-2025
- EPD 07-29-2025
- Dividend Yield
- GSK 4.11%
- EPD 6.90%
- EPS Growth
- GSK N/A
- EPD 4.38
- EPS
- GSK 0.98
- EPD 2.66
- Revenue
- GSK $40,735,668,430.00
- EPD $56,876,000,000.00
- Revenue This Year
- GSK $6.70
- EPD $8.92
- Revenue Next Year
- GSK $5.42
- EPD $9.37
- P/E Ratio
- GSK $18.92
- EPD $11.64
- Revenue Growth
- GSK 2.57
- EPD 9.31
- 52 Week Low
- GSK $31.72
- EPD $27.37
- 52 Week High
- GSK $44.67
- EPD $34.63
- Technical
- Relative Strength Index (RSI)
- GSK 44.51
- EPD 46.19
- Support Level
- GSK $38.15
- EPD $30.73
- Resistance Level
- GSK $38.91
- EPD $31.63
- Average True Range (ATR)
- GSK 0.62
- EPD 0.51
- MACD
- GSK -0.40
- EPD -0.07
- Stochastic Oscillator
- GSK 16.01
- EPD 19.02
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About EPD Enterprise Products Partners L.P.
Enterprise Products Partners is a master limited partnership that transports and processes natural gas, natural gas liquids, crude oil, refined products, and petrochemicals. It is one of the largest midstream companies, with operations servicing most producing regions in the continental US. Enterprise is particularly dominant in the NGL market and is one of the few MLPs that provide midstream services across the full hydrocarbon value chain.